University of Saskatchewan

School of Public Health

Research Units

Below is a list of research units administered by some of our faculty and a few examples of their current research projects:

MERCURi Research Group

The MERCURi Research Group investigates the effect of management practises and structure on the quality of care provided to patients in health care systems.  The group studies executive leadership, first line supervision, organizational culture and the structuring of tasks within hospitals.   They also study the cognate issues of distress, career satisfaction, professional equity, and interprofessional relationships among health care providers.  The MERCURI Research Group uses a multi-disciplinary and mixed methods approach in its studies.

For general inquiries, please email the MERCURi Research Group at mercuri.rg@usask.ca.

Related Areas of inquiry:

Current Projects:

Videos:

Most Recent Publications

Most Recent Conference Presentations and Abstracts

Funding: Core funding for the group's work has been sustained by a series of CIHR grants that have provided continuous funding since 2000. MERCURi faculty have also obtained a variety of grants from Health Canada, Saskatchewan Health, World Health Organization and other sources. Details on these are available on their personal websites.

Population Health Data Laboratory

The Population Health Data Laboratory at the University of Saskatchewan is a secure research facility that houses anonymized population-based administrative health datasets from multiple Canadian provinces. The data laboratory support a program of research to investigate the quality (e.g., accuracy and completeness) of secondary, administrative health data and develop statistical models to address deficiencies in data quality. At present, these methods are being used to investigate multiple chronic diseases, including osteoporosis, hypertension, and Parkinson's disease.

The research conducted in the data laboratory benefits national and provincial agencies and organizations like the Public Health Agency of Canada and Saskatchewan Health, who are increasingly relying on administrative data to inform decision making about population-based health promotion and chronic disease management programs. It also benefits epidemiologists, health services researchers, and clinician scientists who study population health and health services use.

Current Projects:

Funding: Dr. Lix holds funding from the Canadian Institutes of Health Research and the Saskatchewan Health Research Foundation to support graduate students. Interested students should contact Dr. Lix directly to inquire about the availability of funding.

Location of research unit: 501 - 121 Research Drive, Innovation Place, Saskatoon, SK

VIDO/InterVac (Vectored Vaccine Program)

VIDO-InterVac is a world leader in developing vaccines and technologies which protect humans and animals from infectious diseases of public health and economic consequence. The facilities include modern virology, immunology, bacteriology and biochemistry labs and a 160-acre research station. A not-for-profit research centre owned by the University of Saskatchewan, VIDO-InterVac operates with support from the provincial governments of Alberta and Saskatchewan, as well as Government of Canada and industry grants. VIDO's annual operating budget exceeds $12 million.

VIDO-InterVac has worked in the area of vectored vaccines for the past two decades. Vectored viruses have many advantages over conventional vaccines - needle-free delivery, induction of broad long lasting cellular and humoral immunities, economical production and no requirement for strong adjuvants. Live viral vectored vaccines are created by replacing segments of the viral genome with genetic material that represents the disease(s) being targeted by the vaccine. Since adenovirus vectors target mucosal surfaces, we have choosen to work with non human adenoviruses (porcine, bovine) for inducing mucosal immunity - an important consideration given the number of pathogens that enter the body through mucosal surfaces. These vectors are currently being tested for both human and livestock vaccines.

Current Projects:

Adenovirus has been used for many years as a model to study DNA replication, gene expression and virus-host interactions. In recent years, interest has also been focused on its potential use as a vector for vaccination and gene therapy. We have choosen to develop non human adenoviruses (bovine adenovirus [BAdV-]-3; porcine adenovirus [PAdV]-3) as vectors for delivery of vaccines. Since the development of non human adenoviruses as efficient vector(s) requires the basic knowledge about virus and its interactions with the host, the research in the laboratory includes projects both on adenovirus biology and, on the development and use of non human adenoviruses as vectors utilizing a variety of genomic and proteomics techniques. A major focus of the laboratory is to develop and use non human adenoviruses for vaccination of animals and humans. Current areas of research include:

Funding: Funds may be available from NSERC, DRDC, Devolved scholarship and from the University of Saskatchewan. Interested students should contact Dr. Tikoo directly to inquire about the availability of funding.

Location of research unit: VIDO, Univesrity of Saskatchewan, 120 Veterinary Road, Saskatoon, SK

News

Events

Coming Events